CATALYS SYSTEM
Report
- Report Number
- 3005675890-2019-00050
- Event Type
- Injury
- Date Received
- June 3, 2019
- Report Date
- November 12, 2020
- Manufacturer
- JOHNSON & JOHNSON SURGICAL VISION, INC.
- Product Code
- OOE
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
THIS CORRECTION MDR IS BEING SUBMITTED TO ADDRESS INACCURATE INFORMATION IN SECTION F ON THE XML VERSION OF THE PREVIOUS SUBMISSION CAUSED BY A SOFTWARE GLITCH IN THE TRANSMISSION PROCESS. THE INTERNAL NON-CONFORMANCE NUMBERS FOR THIS SOFTWARE ISSUE ARE NR-0148919 AND CAPA-010215.
DATE OF EVENT: DATE UNKNOWN/NOT PROVIDED. (B)(6). SERIAL#: UNKNOWN/NOT PROVIDED. UDI #: A COMPLETE UDI # IS UNKNOWN AS PRODUCT SERIAL NUMBER WAS NOT PROVIDED. PMA/510K: THIS REPORT IS BEING FILED ON AN INTERNATIONAL PRODUCT; LASER CORRECTION SYSTEM, MODEL CATALYS-I, THAT HAS A SIMILAR PRODUCT, CATALYS-U WHICH IS DISTRIBUTED IN THE UNITED STATES UNDER 510(K) # K121091. DEVICE EVALUATED BY MFR: A REVIEW OF RECORDS RELATED TO THE DEVICE INCLUDING LABELING, COMPLAINT TRENDING, AND RISK DOCUMENTATION WILL BE PERFORMED. UPON COMPLETION OF THIS REVIEW, IF THERE IS ANY FURTHER RELEVANT INFORMATION OBTAINED, A SUPPLEMENTAL MEDWATCH WILL BE FILED. DEVICE MANUFACTURE DATE: UNKNOWN, AS THE SERIAL NUMBER OF THE DEVICE WAS NOT PROVIDED. (B)(4). ALL PERTINENT INFORMATION AVAILABLE TO JOHNSON & JOHNSON SURGICAL VISION, INC HAS BEEN SUBMITTED.
IT WAS REPORTED THAT PATIENT HAD CATARACT PROCEDURE WITH SYSTEM AND HAD SIGNIFICANT ENDOTHELIAL CELL LOSS. IT WAS REPORTED THAT SURGEON SIGNIFICANTLY INCREASED THE LASER ENERGY SETTINGS FOR EXPERIMENTAL REASONS. PRE-OPERATIVE ENDOTHELIAL CELL COUNT: 2545 CELLS/MM2, POST-OPERATIVE ENDOTHELIAL CELL COUNT: 1815 CELLS/MM2, PATIENT OUTCOME: FINE (NO VISUAL ACUITY PROBLEMS).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 457877 | CATALYS SYSTEM | CATALYS | OOE | JOHNSON & JOHNSON SURGICAL VISION, INC. | CATALYS-I |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 74 YR | Other |